Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study

Overview of attention for article published in Frontiers in Surgery, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 1 X post from an account with 1,025 followers.

New Research: Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study: Objective The global standard for chemoradiation therapy (CCRT) for head and neck squamous cell… https://t.co

30 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.